Brief: Rani Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results

Rani Therapeutics Holdings

29/03/2022 21:23

March 29 (Reuters) - Rani Therapeutics Holdings Inc
 RANI.O :
    * RANI THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS; PROVIDES CORPORATE UPDATE
    * CASH AND CASH EQUIVALENTS AS OF DECEMBER 31, 2021 WERE
$117.5
MILLION, COMPARED TO $73.1 MILLION AS OF DECEMBER 31, 2020
    * RANI THERAPEUTICS - SEES CASH, CASH EQUIVALENTS BALANCE TO
BE
SUFFICIENT TO FUND OPERATING EXPENSES, CAPEX REQUIREMENTS AT
LEAST UNTIL END OF 2023
    * QTRLY NET LOSS PER CLASS A COMMON SHARE ATTRIBUTABLE TO
RANI
THERAPEUTICS HOLDINGS, INC, BASIC AND DILUTED $0.27
    * Q4 EARNINGS PER SHARE VIEW $-0.50 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX8F4Zqs 
Further company coverage:  RANI.O 

 ((Reuters.Briefs@thomsonreuters.com;))